Kumari et al. [28] demonstrated that the treatment of diabetic rats with vanillic acid markedly attenuated STZ-induced body weight loss and hyperglycemia, along with improved lipid profile and HbA1c, without significant alteration of serum insulin levels. The gene discussed is INS; the disease is Hyperglycemia.